For: | Wang Q, Tang W, Rao WS, Song X, Shan CX, Zhang W. Changes of Ghrelin/GOAT axis and mTOR pathway in the hypothalamus after sleeve gastrectomy in obese type-2 diabetes rats. World J Gastroenterol 2017; 23(34): 6231-6241 [PMID: 28974889 DOI: 10.3748/wjg.v23.i34.6231] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i34/6231.htm |
Number | Citing Articles |
1 |
Renhong Huang, Xusheng Ding, Hongbing Fu, Qingping Cai. Potential mechanisms of sleeve gastrectomy for reducing weight and improving metabolism in patients with obesity. Surgery for Obesity and Related Diseases 2019; 15(10): 1861 doi: 10.1016/j.soard.2019.06.022
|
2 |
Xiaojuan Li, Luming Qiao, Wei Wang, Ying Shi, Lei Yuan, Zhiwei Zhai. Sleeve gastrectomy improves cardiac function and glucose-lipid metabolism disorder in obese rats induced by a high-fat and high-sugar diet. Endocrine Journal 2024; 71(5): 527 doi: 10.1507/endocrj.EJ23-0567
|
3 |
O. V. Kornyushin, A. A. Bakhtyukov, I. I. Zorina, Ya. G. Toropova, K. V. Derkach, O. M. Berko, M. N. Todosenko, L. S. Litvinova, A. O. Shpakov, M. M. Galagudza. The Effect of Different Types of Bariatric Surgery on Metabolic and Hormonal Parameters in Rats with a Decompensated Form of Type II Diabetes Mellitus. Advances in Gerontology 2019; 9(3): 336 doi: 10.1134/S2079057019030081
|
4 |
Kyosuke Takeshita. Sharpening the Focus: Acupuncture Interrupts the Brain–Gut Vicious Cycle Underlying Functional Dyspepsia. Digestive Diseases and Sciences 2020; 65(6): 1578 doi: 10.1007/s10620-020-06080-1
|
5 |
Yoshihiro Shiomi, Makoto Yoshimura, Yuko Hori, Yuta Ohira, Kenji Nagahama, Tomoko Ozaki, Mineo Takei, Takao Tanaka, Tomohide Uno. Z-505, an Oral Ghrelin Receptor Agonist, Attenuates Anorexia After Total Gastrectomy in Rats. Journal of Surgical Research 2020; 246: 527 doi: 10.1016/j.jss.2019.09.035
|
6 |
Daniela Rosendo-Silva, Eduardo Lopes, Tamaeh Monteiro-Alfredo, Inês Falcão-Pires, Hans Eickhoff, Sofia Viana, Flávio Reis, Ana Salomé Pires, Ana Margarida Abrantes, Maria Filomena Botelho, Raquel Seiça, Paulo Matafome. The adipose tissue melanocortin 3 receptor is targeted by ghrelin and leptin and may be a therapeutic target in obesity. Molecular and Cellular Endocrinology 2024; 594: 112367 doi: 10.1016/j.mce.2024.112367
|